SMR1 Antibody

Introduction to SMR1 Antibody

SMR1 (Submandibular Rat 1) is a protein initially identified in rat submandibular glands, playing roles in anti-inflammatory responses and tissue-specific functions . SMR1 antibodies are immunological tools developed to detect and study this protein’s expression, posttranslational modifications, and biological activity. These antibodies have been critical in elucidating SMR1’s distribution across tissues, including salivary glands, lungs, and reproductive organs .

Development and Characterization of SMR1 Antibodies

Polyclonal antibodies against SMR1 were generated using synthetic peptides corresponding to distinct sequences within the protein:

• Anti-SMR1(216): Targets the anti-inflammatory TDIFEGG sequence at the C-terminus .

• Anti-SMR1(219): Binds to the SNPPTQLLSTEAQANTK sequence .

Key Validation Data:

• Specificity: Both antibodies showed no cross-reactivity with unrelated peptides in ELISA .

• Western Blot Performance:

  • Detected SMR1 isoforms ranging from 12–42 kDa, with dominant bands at 19, 21, and 23 kDa in rat submandibular glands .

  • Anti-SMR1(216) showed stronger reactivity with 16-kDa bands, while anti-SMR1(219) preferentially recognized 12-kDa bands .

• 2D Gel Analysis: Revealed 36 distinct SMR1 spots (pI 4–7), confirming extensive posttranslational modifications .

Tissue-Specific Expression of SMR1

SMR1 antibodies have mapped the protein’s expression across rat tissues:

Notable Findings:

• Saliva contains TDIFEGG-containing peptides (<3 kDa) in 77–85% of rats, suggesting bioactive anti-inflammatory fragments .

• SMR1 in the penis is downregulated 82.5-fold post-prostatectomy, linking it to erectile dysfunction .

Posttranslational Modifications of SMR1

SMR1 undergoes significant processing, as revealed by antibody-based assays:

• Glycosylation:

  • N-glycosylation accounts for ~60% of SMR1’s molecular diversity (e.g., 23- and 21-kDa bands reduced to 16/12 kDa after N-glycanase treatment) .

  • No evidence of phosphorylation or O-linked glycosylation .

• Proteolytic Cleavage:

  • Full-length SMR1 (16 kDa) is processed into a 12-kDa fragment (Arg70–C terminus) .

Functional Implications of SMR1 Antibody Studies

• Anti-Inflammatory Activity:

  • Anti-SMR1(216) confirmed TDIFEGG peptides in saliva, which are implicated in reducing pulmonary inflammation .

• Role in Disease Models:

  • Post-prostatectomy erectile dysfunction correlates with SMR1 downregulation in the penis, highlighting its potential therapeutic relevance .

Table 1: SMR1 Immunoreactivity in Saliva Fractions

Table 2: SMR1 Expression Post-Prostatectomy

Applications and Limitations

• Applications:

  • Tracking SMR1 in inflammation models.

  • Studying post-surgical neurogenic dysfunction .

• Limitations:

  • Low protein abundance complicates mass spectrometry analysis .

  • Cross-reactivity with aggregated forms in certain tissues (e.g., lung) .